Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2024

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Oct 15, 2024--

Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a cash dividend for the fourth quarter of 2024 of $1.24 per share on the company’s common stock. The dividend is payable on December 10, 2024 to shareholders of record at the close of business on November 26, 2024. The ex-dividend date is November 26, 2024.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com:https://www.businesswire.com/news/home/20241015885690/en/

CONTACT: Media contact:

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

KEYWORD: NEW JERSEY UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL CLINICAL TRIALS

SOURCE: Johnson & Johnson

Copyright Business Wire 2024.